These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 20656628

  • 1. The genetics and epigenetics of fatigue.
    Landmark-Høyvik H, Reinertsen KV, Loge JH, Kristensen VN, Dumeaux V, Fosså SD, Børresen-Dale AL, Edvardsen H.
    PM R; 2010 May; 2(5):456-65. PubMed ID: 20656628
    [Abstract] [Full Text] [Related]

  • 2. Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome.
    Rajeevan MS, Smith AK, Dimulescu I, Unger ER, Vernon SD, Heim C, Reeves WC.
    Genes Brain Behav; 2007 Mar; 6(2):167-76. PubMed ID: 16740143
    [Abstract] [Full Text] [Related]

  • 3. Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals.
    Buchwald D, Pearlman T, Umali J, Schmaling K, Katon W.
    Am J Med; 1996 Oct; 101(4):364-70. PubMed ID: 8873506
    [Abstract] [Full Text] [Related]

  • 4. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals.
    Glass JM, Lyden AK, Petzke F, Stein P, Whalen G, Ambrose K, Chrousos G, Clauw DJ.
    J Psychosom Res; 2004 Oct; 57(4):391-8. PubMed ID: 15518675
    [Abstract] [Full Text] [Related]

  • 5. Genetic evaluation of the serotonergic system in chronic fatigue syndrome.
    Smith AK, Dimulescu I, Falkenberg VR, Narasimhan S, Heim C, Vernon SD, Rajeevan MS.
    Psychoneuroendocrinology; 2008 Feb; 33(2):188-97. PubMed ID: 18079067
    [Abstract] [Full Text] [Related]

  • 6. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment.
    Inder WJ, Prickett TC, Mulder RT.
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):343-8. PubMed ID: 15730417
    [Abstract] [Full Text] [Related]

  • 7. Neuropsychological performance in persons with chronic fatigue syndrome: results from a population-based study.
    Majer M, Welberg LA, Capuron L, Miller AH, Pagnoni G, Reeves WC.
    Psychosom Med; 2008 Sep; 70(7):829-36. PubMed ID: 18606722
    [Abstract] [Full Text] [Related]

  • 8. Possible role for early-life immune insult including developmental immunotoxicity in chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME).
    Dietert RR, Dietert JM.
    Toxicology; 2008 May 02; 247(1):61-72. PubMed ID: 18336982
    [Abstract] [Full Text] [Related]

  • 9. An integrated approach to infer causal associations among gene expression, genotype variation, and disease.
    Lee E, Cho S, Kim K, Park T.
    Genomics; 2009 Oct 02; 94(4):269-77. PubMed ID: 19540336
    [Abstract] [Full Text] [Related]

  • 10. Association of peripheral inflammatory markers with chronic fatigue in a population-based sample.
    Raison CL, Lin JM, Reeves WC.
    Brain Behav Immun; 2009 Mar 02; 23(3):327-37. PubMed ID: 19111923
    [Abstract] [Full Text] [Related]

  • 11. Chronic fatigue syndrome: an update focusing on phenomenology and pathophysiology.
    Cho HJ, Skowera A, Cleare A, Wessely S.
    Curr Opin Psychiatry; 2006 Jan 02; 19(1):67-73. PubMed ID: 16612182
    [Abstract] [Full Text] [Related]

  • 12. Polymorphisms in the brain-specific thyroid hormone transporter OATP1C1 are associated with fatigue and depression in hypothyroid patients.
    van der Deure WM, Appelhof BC, Peeters RP, Wiersinga WM, Wekking EM, Huyser J, Schene AH, Tijssen JG, Hoogendijk WJ, Visser TJ, Fliers E.
    Clin Endocrinol (Oxf); 2008 Nov 02; 69(5):804-11. PubMed ID: 18410547
    [Abstract] [Full Text] [Related]

  • 13. A functional polymorphism in the disrupted-in schizophrenia 1 gene is associated with chronic fatigue syndrome.
    Fukuda S, Hashimoto R, Ohi K, Yamaguti K, Nakatomi Y, Yasuda Y, Kamino K, Takeda M, Tajima S, Kuratsune H, Nishizawa Y, Watanabe Y.
    Life Sci; 2010 May 08; 86(19-20):722-5. PubMed ID: 20227423
    [Abstract] [Full Text] [Related]

  • 14. Chronic fatigue syndrome: a hypothesis focusing on the autonomic nervous system.
    Pagani M, Lucini D.
    Clin Sci (Lond); 1999 Jan 08; 96(1):117-25. PubMed ID: 9857114
    [Abstract] [Full Text] [Related]

  • 15. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome.
    Buchwald D, Wener MH, Pearlman T, Kith P.
    J Rheumatol; 1997 Feb 08; 24(2):372-6. PubMed ID: 9034999
    [Abstract] [Full Text] [Related]

  • 16. Posttraumatic stress disorder and physical comorbidity among female children and adolescents: results from service-use data.
    Seng JS, Graham-Bermann SA, Clark MK, McCarthy AM, Ronis DL.
    Pediatrics; 2005 Dec 08; 116(6):e767-76. PubMed ID: 16322133
    [Abstract] [Full Text] [Related]

  • 17. Chronic ACTH autoantibodies are a significant pathological factor in the disruption of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome, anorexia nervosa and major depression.
    Wheatland R.
    Med Hypotheses; 2005 Dec 08; 65(2):287-95. PubMed ID: 15885924
    [Abstract] [Full Text] [Related]

  • 18. Distinguishing patients with chronic fatigue from those with chronic fatigue syndrome: a diagnostic study in UK primary care.
    Darbishire L, Ridsdale L, Seed PT.
    Br J Gen Pract; 2003 Jun 08; 53(491):441-5. PubMed ID: 12939888
    [Abstract] [Full Text] [Related]

  • 19. Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome.
    Van Den Eede F, Moorkens G, Van Houdenhove B, Cosyns P, Claes SJ.
    Neuropsychobiology; 2007 Jun 08; 55(2):112-20. PubMed ID: 17596739
    [Abstract] [Full Text] [Related]

  • 20. Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.
    Van Den Eede F, Moorkens G, Hulstijn W, Van Houdenhove B, Cosyns P, Sabbe BG, Claes SJ.
    Psychol Med; 2008 Jul 08; 38(7):963-73. PubMed ID: 17803834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.